Inventor
MAVUNKEL BABU J
US21 patents
⚠️ This page may combine multiple inventors who share the name “MAVUNKEL BABU J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCIOS INC
16 patentsUS6867209B1Mar 15, 2005
Indole-type derivatives as inhibitors of p38 kinase
SCIOS INC72 citations98
US6589954B1Jul 8, 2003
Compounds and methods to treat cardiac failure and other disorders
SCIOS INC78 citations98
US6130235AOct 10, 2000
Compounds and methods to treat cardiac failure and other disorders
SCIOS INC123 citations98
US6541477B2Apr 1, 2003
Inhibitors of p38-a kinase
SCIOS INC59 citations94
US6448257B1Sep 10, 2002
Compounds and methods to treat cardiac failure and other disorders
SCIOS INC44 citations92
US6410540B1Jun 25, 2002
Inhibitors of p38-αkinase
SCIOS INC53 citations92
US6340685B1Jan 22, 2002
Compounds and methods to treat cardiac failure and other disorders
SCIOS INC28 citations92
US7214679B2May 8, 2007
Piperidine/piperazine-type inhibitors of p38 kinase
SCIOS INC10 citations80
US7304048B2Dec 4, 2007
Indole-type derivatives as inhibitors of p38 kinase
SCIOS INC7 citations74
US6864260B2Mar 8, 2005
Indole-type derivatives as inhibitors of p38 kinase
SCIOS INC6 citations74
US7238712B2Jul 3, 2007
Indole-type derivatives as inhibitors of p38 kinase
SCIOS INC1 citations63
US7189726B2Mar 13, 2007
Benzofuran derivatives as inhibitors of p38-α kinase
SCIOS INC1 citations63
US5610142AMar 11, 1997
Bradykinin antagonist pseudopeptide derivatives of substituted 4-keto-1,3,8-triazaspiro[4.5]decan-3-alkanoic acids
SCIOS INC4 citations63
US7220763B2May 22, 2007
Indole-type derivatives as inhibitors of p38 kinase
SCIOS INC5 citations62
US7189739B2Mar 13, 2007
Compounds and methods to treat cardiac failure and other disorders
SCIOS INC0 citations52
US7488744B2Feb 10, 2009
Indole-type derivatives as inhibitors of p38 kinase
SCIOS INC0 citations51
NOVA PHARM CORP
2 patentsUS4889860ADec 26, 1989
Oximes of oxymorphone, naltrexone and naloxone as potent, selective opioid receptor agonists and antagonists
NOVA PHARM CORP144 citations98
US4760069AJul 26, 1988
Oximes of oxymorphone, naltrexone and naloxone as potent, selective opioid receptor agonists and antagonists
NOVA PHARM CORP135 citations97